美國Vermillion
Vermillion, Inc(NASDQ:VRML)成立於1993年,總部位於美國加州是一家致力于開發和發展新型高價值診斷測試并將其進行商業化推廣的公司。其新型高價值診斷測試可以有助于病人的物理診斷,治療和改進治療結果。Vermillion連同其在業界享有盛譽的科學合作者共同致力于腫瘤,血液病,心血管已經婦女健康方面的診斷方案研究。
Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health.